[1]
Reczka, K. et al. 2026. EXPANDING THERAPEUTIC HORIZONS OF GLP-1 RECEPTOR AGONISTS: FROM METABOLIC REGULATION TO NEUROPROTECTION IN ALZHEIMER’S DISEASE AND ADDICTION DISORDERS – A COMPREHENSIVE REVIEW. International Journal of Innovative Technologies in Social Science. 1, 4(52) (Oct. 2026). DOI:https://doi.org/10.31435/ijitss.4(52).2026.6289.